Trials / Conditions / Peripheral T Cell Lymphoma, Unspecified
Peripheral T Cell Lymphoma, Unspecified
4 registered clinical trials studyying Peripheral T Cell Lymphoma, Unspecified.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD3 NCT05208853 | Zhejiang University | EARLY_Phase 1 |
| Completed | RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas NCT01198665 | Samsung Medical Center | Phase 1 / Phase 2 |
| Terminated | Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas NCT00704691 | University of Alabama at Birmingham | EARLY_Phase 1 |
| Unknown | Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP NCT00725231 | University of Göttingen | Phase 3 |